European evidence based consensus on the diagnosis and management of Crohn's disease:: definitions and diagnosis

被引：428

作者：

Stange, EF ^{[1
]}

Travis, SPL

Vermeire, S

Beglinger, C

Kupcinskas, L

Geboes, K

Barakauskiene, A

Villanacci, V

Von Herbay, A

Warren, BF

Gasche, C

Tilg, H

Schreiber, SW

Schölmerich, J

Reinisch, W

机构：

[1] John Radcliffe Hosp, Dept Histopathol, Oxford OX3 9DU, England

[2] Robert Bosch Krankenhaus, Dept Internal Med 1, Innere Med Abt 1, Schwerpunkte Gastroenterol Hepatol & Endokrinol, D-70341 Stuttgart, Germany

[3] Univ Hosp KULeuven, Dept Pathol, Louvain, Belgium

[4] Univ Basel Hosp, Dept Gastroenterol, CH-4031 Basel, Switzerland

[5] Kaunas Univ Med Hosp, Dept Gastroenterol, Kaunas, Lithuania

[6] Vilnius Univ Hosp, Gastroenterol Clin, Vilnius, Lithuania

[7] Univ Brescia, Spedali Civili Brescia, UO Chirurg Gen 1, Cattedra Chirurg Gen, Brescia, Italy

[8] St Marks Hosp, Harrow, Middx, England

[9] Med Univ Vienna, Dept Internal Med 4, Div Gastroenterol & Hepatol, Vienna, Austria

[10] Univ Innsbruck Hosp, Dept Med, A-6020 Innsbruck, Austria

[11] Univ Hosp Schleswig Holstein UKSH, Dept Gen Internal Med, Kiel, Germany

[12] Univ Regensburg, Dept Internal Med 1, D-8400 Regensburg, Germany

[13] Univ Klin Innere Med 4, Gastroenterol & Hepatol Abt, Vienna, Austria

来源：

GUT | 2006年 / 55卷

关键词：

D O I：

10.1136/gut.2005.081950a

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：i1 / i15

页数：15

共 166 条

[21] In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis [J].

Bridger, S ;

Lee, JCW ;

Bjarnason, I ;

Jones, JEL ;

Macpherson, AJ .

GUT, 2002, 51 (01) :21-25

[22] A LABORATORY INDEX FOR PREDICTING RELAPSE IN ASYMPTOMATIC PATIENTS WITH CROHNS-DISEASE [J].

BRIGNOLA, C ;

CAMPIERI, M ;

BAZZOCCHI, G ;

FARRUGGIA, P ;

TRAGNONE, A ;

LANFRANCHI, GA .

GASTROENTEROLOGY, 1986, 91 (06) :1490-1494

[23] IMPORTANCE OF LABORATORY PARAMETERS IN THE EVALUATION OF CROHNS-DISEASE ACTIVITY [J].

BRIGNOLA, C ;

LANFRANCHI, GA ;

CAMPIERI, M ;

BAZZOCCHI, G ;

DEVOTO, M ;

BONI, P ;

FARRUGGIA, P ;

VEGGETTI, S ;

TRAGNONE, A .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1986, 8 (03) :245-248

[24] PLACEBO-CONTROLLED TRIAL OF ORAL 5-ASA IN RELAPSE PREVENTION OF CROHNS-DISEASE [J].

BRIGNOLA, C ;

IANNONE, P ;

PASQUALI, S ;

CAMPIERI, M ;

GIONCHETTI, P ;

BELLUZZI, A ;

BASSO, O ;

MIGLIOLI, M ;

BARBARA, L .

DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (01) :29-32

[25]

BROOKE BN, 1959, LANCET, V2, P745

[26]

CAPRILLI R, 1994, ALIMENT PHARM THER, V8, P35

[27] Guidelines for the management of inflammatory bowel disease in adults [J].

Carter, MJ ;

Lobo, AJ ;

Travis, SPL .

GUT, 2004, 53 :v1-v16

[28] Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve [J].

Cherian, S ;

Singh, P .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2324-2329

[29] Accuracy of enteroclysis in Crohn's disease of the small bowel: a retrospective study [J].

Cirillo, LC ;

Camera, L ;

Della Noce, M ;

Castiglione, F ;

Mazzacca, G ;

Salvatore, M .

EUROPEAN RADIOLOGY, 2000, 10 (12) :1894-1898

[30] Biological markers of short term relapse in Crohn's disease (CD) [J].

Consigny, Y ;

Modigliani, R ;

Colombel, JF ;

Dupas, JL ;

Mary, JY .

GASTROENTEROLOGY, 2001, 120 (05) :A141-A141

← 1 2 3 4 5 6 7 8 9 10 →